Shoonya Upgrades to Trading-cum-Clearing Member (TM-CM) on MCX
PRNewswire
Mohali (Punjab) [India], May 21: Shoonya by Finvasia has officially announced its upgrade from a Trading Member (TM) to a Trading-cum-Clearing Member (TM-CM) on the Multi Commodity Exchange (MCX). The transition took place after market hours on Friday, May 16, 2025, and has been fully operational from Monday, May 19, 2025.
This milestone marks a significant enhancement in Shoonya's operational capabilities. By becoming a TM-CM, Shoonya will now clear all MCX trades internally without the involvement of any external clearing member. The clearing cost has now been reduced from Rs. 50 per crore to Rs. 0. The move reflects the company's long-term strategy to build stronger back-end efficiencies while extending the benefits directly to its users.
Speaking on the development, Sarvjeet Singh Virk, Co-founder and Managing Director of Finvasia, said, "At Shoonya, our mission has always been to make investing affordable and efficient for every Indian. Upgrading to a TM-CM on MCX is a key milestone in that journey, one that eliminates clearing costs and enables faster, and secure settlements. It is yet another example of how we're investing in technology and tech-related solutions to deliver a simplified, intuitive and frictionless user experience."
There will be no impact on users during this transition. All open positions, holdings, deposits, and trading access will remain unchanged. This upgrade underscores Shoonya's vision of delivering a modern investment experience where efficiency, transparency, and long-term value come standard.
About Shoonya by Finvasia
Shoonya by Finvasia is a multi-asset trading platform, boasting low commission across 16 investing touch-points like clearing, technology, monthly maintenance etc. Placing customer experience at the core, the distinctive platform offers data-powered signal-based analysis to help investors and traders identify the best investment opportunities and make informed decisions. This focus has driven customer preference as the platform's active user base more than doubled in FY2023, which now stands at over 4 lakhs.
The platform is one of the few non-bank clearing members in India, clearing and settling trades executed by Trading Members (TMs) and Foreign Portfolio Investors (FPIs) in Equity, Futures Options and Currency Derivatives segments on NSE, BSE, MCX and NCDEX.
Shoonya was founded by Sarvjeet Virk (MD) and Tajinder Virk (CEO), Ex-Wall Street Professionals, with deep financial expertise. They envisioned to empower Indian traders and investors by enabling them to make smart financial decisions and achieve investment goals through an innovative and user-friendly trading platform.
The company received FDI funding from some of the industry's notable Venture Capitalists against a valuation of INR 1.5 Billion in 2016, which enabled it to achieve its guiding mission to cut the cost that makes trading expensive and offer technology-driven financial services to its clients.
Website: https://shoonya.com/
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India Today
16 minutes ago
- India Today
India slashes EV import duties to 15% to attract global carmakers
In a major move to boost electric vehicle (EV) manufacturing and adoption, the Ministry of Heavy Industries has unveiled a new policy titled 'Scheme to Promote Manufacturing of Electric Passenger Cars in India' (SPMEPCI). The initiative significantly reduces import duties on electric vehicles from 110 per cent to just 15 per cent, aiming to lure global automakers into investing in India's EV incentivesTo benefit from the reduced import tariff, automakers must commit to investing at least Rs 4,150 crore (approximately $500 million) within three years toward manufacturing electric cars in India. The policy allows manufacturers to use existing production facilities, although previous investments and land/building costs are not counted towards the mandatory investment return, the reduced 15 per cent customs duty will apply for a five-year period, capped at 8,000 imported electric vehicles annually—provided each unit is priced above $35,000 (approx Rs 30 lakh). The annual quota is flexible, allowing carryover of unused units, and total benefits are limited to Rs 6,484 crore or the actual investment made—whichever is targets and milestones Participating carmakers must meet a series of performance targets, including:Annual turnover of Rs 2,500 crore by the second year,Rs 5,000 crore by the fourth year, andRs 7,500 crore by the fifth addition, companies must:Set up local manufacturing facilities by the third year,Achieve 25 per cent local value addition by the third year, andIncrease this to 50 per cent by the fifth investment expenses include R&D, machinery, and charging infrastructure (up to 5 per cent of the total investment). Land and buildings used directly for manufacturing can account for up to 10 per Industries Minister HD Kumaraswamy confirmed that several global automakers—Hyundai, Kia, Mercedes-Benz, Skoda, and Volkswagen—have already expressed interest in availing the scheme's Tesla is unlikely to participate in local manufacturing. Despite its long-awaited entry into the Indian market in 2025, the American EV company reportedly plans only to open showrooms and import vehicles—making its offerings subject to the full 110 per cent import duty."Tesla is not expected to invest in manufacturing here. They are likely to begin with showrooms only,' Kumaraswamy requirementsTo apply for the scheme, carmakers must meet the following global financial benchmarks:A minimum of Rs 10,000 crore in annual automotive revenueAt least Rs 3,000 crore in fixed online portal for SPMEPCI applications is expected to go live soon, with approval letters to be issued from August 2025 to Auto Today Magazine
&w=3840&q=100)
Business Standard
16 minutes ago
- Business Standard
RBI rate cut hopes lift Sensex, Nifty; banks and Reliance lead gains
Indian equities climbed on Thursday as investors anticipated a rate cut by the Reserve Bank of India (RBI). The Sensex rose 444 points (0.5 per cent) to close at 81,442, while the Nifty gained 131 points (0.5 per cent) to settle at 24,751. The rally was led by strong performances in ICICI Bank and Reliance Industries. Reliance Industries advanced after JP Morgan raised its target price, citing improved earnings prospects. ICICI Bank gained on expectations of a third consecutive rate cut by the RBI on Friday, with subdued inflation providing room to prioritise economic growth. HDFC Bank also contributed to the gains, rising 0.5 per cent. Sectorally, rate-sensitive stocks—including PSU banks, NBFCs and auto—remained in focus. Pharma and healthcare indices rose over a per cent each amid optimism around a potential India–US trade deal, as American officials held talks in New Delhi. A dip in the US 10-year bond yield, reflecting a slowing US economy, further supported sentiment in emerging markets like India. Market breadth remained strong, with 2,257 stocks advancing against 1,725 declines. Nearly two-thirds of Sensex constituents ended higher, with Eternal leading the pack—soaring 4.5 per cent and emerging as the third-largest contributor to the index's gains. Ajit Mishra, SVP–research at Religare Broking, noted, 'The Nifty has reclaimed its 20-daily exponential moving average. Sustaining above this level is crucial for further upside; otherwise, profit-taking could resurface.' Going forward, global cues—including US trade negotiations and economic trends—will influence market direction.
The Hindu
17 minutes ago
- The Hindu
LIC raises stake in Dr. Reddy's
Life Insurance Corporation of India's stake in Dr. Reddy's Laboratories raced past the 8% mark recently with the country's largest institutional investor acquiring an additional, more than 2% in the generic drugmaker since October 2024. From about 6.20%, the holding increased to 8.21% in a period of less than eight months through open market purchases. In terms of number of shares, LIC had acquired more than 1.67 crore during this period, the Hyderabad-headquartered pharma major said in a filing. Dr. Reddy's shares closed 3.01% higher on Thursday at ₹1,289.90 apiece on the BSE.
